Suppr超能文献

儿童脑型疟疾。肝素、地塞米松与安慰剂的对比研究。

Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo.

作者信息

Rampengan T H

机构信息

Department of Child Health, Medical School Sam Ratulangi University/Gunung Wenang Hospital Manado, Indonesia.

出版信息

Paediatr Indones. 1991 Jan-Feb;31(1-2):59-66.

PMID:1852471
Abstract

From January 1987 up to April 1990, sixty two patients diagnosed as cerebral malaria were admitted to the Department of Child Health, Medical School Sam Ratulangi University, Gunung Wenang General Hospital were included in this study. They were treated with quinine dihydrochloride intravenously continued orally for a total of 7 days combined with fansidar by nasogastric tube for 2 days. All patients were also receiving intravenous fluid drips and other symptomatic treatment. They were divided into three groups. Group I received heparin 300 u/kg body weight intramuscularly once daily for 3 consecutive days; group II received dexamethasone 0.5 mg/kg body weight intravenously, three times daily for three consecutive days; group III didn't receive dexamethasone nor heparin. The mortality rate of the three group combined was 1 out of 21 patients (1.61%). In group I, all 21 patients were alive. One out of 21 patients of group II died (4.76%). In group III, all 20 patients were alive. The average period of regaining consciousness was 1.45 days in group I, 2.85 days in group II and 2.76 days in group III. There was a significant difference between group I and II, and also between group I and III. The average duration of fever was 2.60 days in group I, 2.40 days in group II and 3.69 days in group III. There was a significant difference between group I and III and also between group II and III. The average hospitalization days was 8.0 days in group I, 11.1 days in group II and 10.5 days in group III.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

从1987年1月至1990年4月,62例被诊断为脑型疟疾的患者入住三马林达大学医学院儿童健康系、古农韦南综合医院,并被纳入本研究。他们接受了静脉注射二盐酸奎宁,随后口服,共7天,同时通过鼻饲管给予 Fansidar(周效磺胺-乙胺嘧啶复方制剂)2天。所有患者还接受了静脉输液和其他对症治疗。他们被分为三组。第一组每天肌肉注射肝素300单位/千克体重,连续3天;第二组每天静脉注射地塞米松0.5毫克/千克体重,连续3天,每日3次;第三组既未接受地塞米松也未接受肝素治疗。三组患者合并的死亡率为21例中有1例(1.61%)。在第一组中,所有21例患者均存活。第二组21例患者中有1例死亡(4.76%)。在第三组中,所有20例患者均存活。第一组恢复意识的平均时间为1.45天,第二组为2.85天,第三组为2.76天。第一组和第二组之间以及第一组和第三组之间存在显著差异。第一组发热的平均持续时间为2.60天,第二组为2.40天,第三组为3.69天。第一组和第三组之间以及第二组和第三组之间存在显著差异。第一组的平均住院天数为8.0天,第二组为11.1天,第三组为10.5天。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验